Home Trending Stocks BriaCell Therapeutics Corp. (BCTX) Stock Skyrockets Following Disclosure of Overall Survival (OS)...

BriaCell Therapeutics Corp. (BCTX) Stock Skyrockets Following Disclosure of Overall Survival (OS) Reports

BriaCell Therapeutics Corp. (BCTX) stock prices were down by a marginal 2.75% as of the market closing on June 1st, 2021, bringing the price per share up to USD$3.18 at the end of the trading day. Subsequent current market fluctuations have seen the stock skyrocket by 99.69% to hit USD$6.35.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

OS Update

The clinical stage biotechnology company provided an update on June 2nd, 2021 on the overall survival (OS) data on its previously announced advanced breast cancer patients. These women were administered BCTX’s lead candidate Bria-IMT as monotherapy, as well as in conjunction with checkpoint inhibitors. These inhibitors include prembrulizumab and Incyte’s retifanlimab

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

HLA-Typing

The body’s immune response is triggered by cells with human leukocyte antigen (HLA) on their surface. BCTX’s proprietary immunotherapy treatment appears most effective when the patient’s HLA-type corresponds to Bria-IMT, allowing the company to potentially identify patients that are most likely to respond. HLA-typing is a highly accessible test, which is simple to use and available widely.

Top Responder Overview

September 19th, 2019 saw the emphasis by BCTX on a patient’s positive response to BriaCell’s treatment, with a follow-up on January 13th, 2020. Before the administering of BCTX’s treatment, the patient had received 12 regimens with 16 agents. Despite this, her condition worsened, resulting in a gruesome orbital tumor, which metastasized behind her left eye to the extent of causing her eye to bulge from its socket.

Success of BCTX Treatment

Six months after the commencement of BCTX’s treatment, the patient’s orbital tumor was reported to have been completely eliminated. This resulted in the patient surviving for over 21 months, which is a monumentally significant clinical benefit.

Scope of Treatment

The CEO of BCTX highlighted the failure of currently available treatments to adequately address the fight against advanced breast cancer that women have been diagnosed with. To this end, the company was pleased to announce the success of its immunotherapy regimen, which serves to offer clinical benefits for patients in dire need of new therapy options.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for BCTX

Armed with the massive surge in stock price, BCTX is poised to capitalize on this recent development and facilitate the proliferation of their treatment. Following the expansion and consolidation of their footprint, the company is hopeful for a continued trajectory of success. Current and potential investors are hopeful that management will be able to leverage the resources at their disposal to facilitate significant and sustained increases in shareholder value.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why Accuray Incorporated (ARAY) stock had a good Wednesday?

Accuray Incorporated (ARAY) shares rose 4.86% in after-hours on Wednesday, June 23, 2021, and closed at $4.75 per share. Earlier in the morning session,...

Reto Eco-Solutions Inc. (RETO) stock declines during after-hour session. Let’s see why?

Reto Eco-Solutions Inc. (NASDAQ: RETO) stock gained by 12.82% at last close whereas the RETO stock-price fell by 5.3% in the after-hour session. ReTo...

Adial Pharmaceuticals Inc. (ADIL) stock plunged during pre-market trading. Here’s to know why?

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) stock gained by 9.06% at last close while the ADIL share price fell by 6.07% in the pre-market trading...

Why AbCellera Biologics Inc. (ABCL) stock faced negativity on Tuesday?

AbCellera Biologics Inc. (ABCL) shares lost 2.13% in after-hours on Tuesday, June 22, 2021, and closed the day at $21.60 per share. Earlier, ABCL's...

Biocept Inc. (BIOC) stock surged during current market trading. Why is it so?

Biocept Inc. (NASDAQ: BIOC) stock gained by 3.13% in the current market trading. Biocept creates and sells molecular diagnostic tests that offer doctors with...

Trilogy Metals Inc. (TMQ) stock surged during pre-market, given no current update

Trilogy Metals Inc. (NASDAQ: TMQ) stock fell by 5.12% at last close whereas the TMQ stock price gained by 5.81% in the pre-market trading....

How Capricor Therapeutics Inc (CAPR) stock recover its early loss in the after-hours on Wednesday?

Capricor Therapeutics Inc. (CAPR) shares went up 7.28% in after-hours on Wednesday, June 23, 2021, and closed the day at $5.60 per share. Earlier...

Why Accuray Incorporated (ARAY) stock had a good Wednesday?

Accuray Incorporated (ARAY) shares rose 4.86% in after-hours on Wednesday, June 23, 2021, and closed at $4.75 per share. Earlier in the morning session,...

Related News

Why Accuray Incorporated (ARAY) stock had a good Wednesday?

Accuray Incorporated (ARAY) shares rose 4.86% in after-hours on Wednesday, June 23, 2021, and closed at $4.75 per share. Earlier in the morning session,...

Reto Eco-Solutions Inc. (RETO) stock declines during after-hour session. Let’s see why?

Reto Eco-Solutions Inc. (NASDAQ: RETO) stock gained by 12.82% at last close whereas the RETO stock-price fell by 5.3% in the after-hour session. ReTo...

Adial Pharmaceuticals Inc. (ADIL) stock plunged during pre-market trading. Here’s to know why?

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) stock gained by 9.06% at last close while the ADIL share price fell by 6.07% in the pre-market trading...

Why AbCellera Biologics Inc. (ABCL) stock faced negativity on Tuesday?

AbCellera Biologics Inc. (ABCL) shares lost 2.13% in after-hours on Tuesday, June 22, 2021, and closed the day at $21.60 per share. Earlier, ABCL's...

Biocept Inc. (BIOC) stock surged during current market trading. Why is it so?

Biocept Inc. (NASDAQ: BIOC) stock gained by 3.13% in the current market trading. Biocept creates and sells molecular diagnostic tests that offer doctors with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

7542

GIFT

Download free eBook for 

7 GROWTH  STOCKS FOR 2021

WAIT 
WE HAVE GIFT FOR YOU

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam